Effect of age at onset on frequency of depression in Parkinson's disease

Kostíc, V S; Filipović, S R; Lecić, D; Momcilović, D; Sokić, D; Sternić, N
October 1994
Journal of Neurology, Neurosurgery & Psychiatry;Oct1994, Vol. 57 Issue 10, p1265
Academic Journal
No abstract available.


Related Articles

  • Citations and Clinicians' Notes: Neurology and Psychiatry: Parkinson's Disease.  // Current Medical Literature: Health Care of Older People;2003, Vol. 16 Issue 4, p95 

    Presents a comparative study of Parkinson's disease (PD) with old-age onset and middle-age onset. Assessment of motor impairment; Treatment recommendations.

  • EVALUAREA SIMPTOMELOR NONMOTORII LA PACIENÅ¢II CU BOALÄ‚ PARKINSON PRECOCE. Tohănean, Nicoleta; Perju-Dumbravă, Lăcrămioara // Clujul Medical;Jun2012, Vol. 85 Issue 2, p212 

    Introduction. Parkinson's disease is the second most frequent neurodegenerative disorder. Early diagnosis is important to provide effective management with a better prognosis for the patient. A variety of non-motor symptoms appear before the classic al motor symptoms of Parkinson's disease....

  • Apolipoprotein E genotypes do influence the age of onset in Huntington's disease. Soft, C.; Andrich, J. E.; Brune, N.; Gencik, M.; Kraus, P. H.; Przuntek, H.; Epplen, J. T. // Journal of Neurology, Neurosurgery & Psychiatry;Dec2004, Vol. 75 Issue 12, p1692 

    Objective: The ϵ4 allele of the apolipoprotein E (ApoE) gene has been defined as a critical factor for early onset neurodegeneration in Pick's, Parkinson's, and Alzheimer's disease. Unexpectedly, the ϵ4 allele appeared to delay the age of onset in Huntington's disease (HD) patients....

  • Non-SMC condensin I complex, subunit D2 gene polymorphisms are associated with Parkinson's disease: a Han Chinese study. Zhang, Ping; Liu, Ling; Huang, Jinsha; Shao, Liang; Wang, Hongcai; Xiong, Nian; Wang, Tao; Bell, J.B. // Genome;2014, Vol. 57 Issue 5, p253 

    Previous studies have indicated that non-SMC condensin I complex, subunit D2 (NCAPD2), an important protein in chromosome condensation, gene polymorphisms are associated with Alzheimer's disease. But no study has shown the relationship between NCAPD2 polymorphisms and Parkinson's disease. Here,...

  • How do I sound to me? Perceived changes in communication in Parkinson's disease. Miller, Nick; Noble, Emma; Jones, Diana; Allcock, Liesl; Burn, David J. // Clinical Rehabilitation;Jan2008, Vol. 22 Issue 1, p14 

    Objective: To examine self and carer perceived changes in communication associated with Parkinson's disease and relate these to speech intelligibility, gender, age and other disease measures. Design: Cross-sectional survey of a hospital- and community-based sample of 176 people with Parkinson's...

  • LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson’s disease compared to late-onset patients. Kam Yin Chan, Daniel; Ping Wing Ng; Mok, Vincent; Yeung, Jonas; Zhi Ming Fang; Clarke, Raymond; Leung, Edward; Wong, Lawrence // Journal of Neural Transmission;Sep2008, Vol. 115 Issue 9, p1275 

    The frequency of LRRK2 Gly2385Arg mutation in Hong Kong Chinese with early-onset (age ≤45 years) Parkinson’s disease was identified and compared with late-onset patients (age >50 years) and controls. The mutation prevalence were 8.8, 8.3, and 0% for early-onset, late-onset, and...

  • Iowa Gambling Task in patients with early-onset Parkinson's disease: strategy analysis. Gescheidt, Tomáš; Czekóová, Kristína; Urbánek, Tomáš; Mareček, Radek; Mikl, Michal; Kubíková, Radka; Telecká, Sabina; Andrlová, Hana; Husárová, Ivica; Bareš, Martin // Neurological Sciences;Dec2012, Vol. 33 Issue 6, p1329 

    The aim of our study was to analyse decision making in early-onset Parkinson's disease (PD) patients performing the Iowa Gambling Task (IGT). We compared 19 patients with early-onset PD (≤45 years) on dopaminergic medication (no evidence of depression, dementia, executive dysfunction...

  • Juvenil Parkinson Tedavisi Sürecinde GeliÅŸen Psikozda Ketiapin Kullanımı: Bir Olgu Sunumu. Sezgin, Esra; Tomruk, Nesrin B.; Alpay, Nihat // Archives of Neuropsychiatry / Noropsikiatri Arsivi;2009, Vol. 46 Issue 1, p24 

    Parkinson's disease (PD), which generally has a late onset (between age 50 and 60), is a chronic disease with a gradual progression. Juvenile Parkinson's disease (JP) describes Parkinsonism manifesting before age 21. There is a high incidence of positive family history in JP. Besides motor...

  • Successful Use of Rasagiline in Combination with Two Antidepressants: A Case Report. Kaur, Narpinder; Madan, Rohit; Sharma, Ashish // Innovations in Clinical Neuroscience;Nov/Dec2012, Vol. 9 Issue 11/12, p39 

    Parkinson's disease is the second most common neurodegenerative disorder, affecting 1 to 2 percent of people older than 60 years. Recent reviews show that depression is a common and potentially debilitating aspect of Parkinson's disease, affecting 40 to 50 percent of patients. Depression in...

  • Impact of Combined Subthalamic Nucleus and Substantia Nigra Stimulation on Neuropsychiatric Symptoms in Parkinson’s Disease Patients. Hidding, U.; Gulberti, A.; Horn, A.; Buhmann, C.; Hamel, W.; Koeppen, J. A.; Westphal, M.; Engel, A. K.; Gerloff, C.; Weiss, D.; Moll, C. K. E.; Pötter-Nerger, M. // Parkinson's Disease (20420080);1/26/2017, p1 

    The goal of the study was to compare the tolerability and the effects of conventional subthalamic nucleus (STN) and combined subthalamic nucleus and substantia nigra (STN+SNr) high-frequency stimulation in regard to neuropsychiatric symptoms in Parkinson’s disease patients. In this single...


Read the Article


Sign out of this library

Other Topics